MediMedia Managed Markets
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In






FDA Approves Pennsaid 2% (Diclofenac Topical Solution) for Pain of Knee OA

First twice-daily topical NSAID for this indication (January 17)

The FDA has approved the New Drug Application (NDA) for Pennsaid (diclofenac sodium topical solution) 2% w/w (Pennsaid 2%).

Pennsaid 2% is a follow-on product to the original Pennsaid (diclofenac sodium topical solution) 1.5% w/w (Pennsaid 1.5%), which has been marketed by Mallinckrodt in the U.S. since 2010.

Pennsaid 2% will be the first twice-per-day dosed topical nonsteroidal anti-inflammatory drug (NSAID) available in the U.S. for treatment of the pain of osteoarthritis of the knee.

Source: Nuvo Research Inc.; January 17, 2014.

More stories